Low-Dose Hormonal Contraception After Liver Transplantation

Transplantation Proceedings

Volumn 39, Issue 5, 2007, Pages 1530-1532

  Jabiry Zieniewicz, Z ^a   Bobrowska, K ^a   Kaminski, P ^a   Wielgos, M ^a   Zieniewicz, K ^a   Krawczyk, M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLUCOSE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE MONITORING; BODY MASS; CLINICAL ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FERTILITY; GRAFT REJECTION; HORMONAL THERAPY; HUMAN; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; MENSTRUAL CYCLE; PREGNANCY; PRIORITY JOURNAL;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; LIVER TRANSPLANTATION; RETROSPECTIVE STUDIES; SAFETY;

EID: 34250195670     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.02.063     Document Type: Article

References (10)

1. Mass K., Quint E.H., Punch M., et al. Gynecological and reproductive function after liver transplantation. Transplantation 62 (1996) 476
2. Parolin M.B., Rabinovitz I., Urbanetz A.A., et al. Impact of successful liver transplantation on reproductive function and sexuality in women with advanced liver disease. Transplant Proc 36 (2004) 943
3. Riely C.A. Contraception and pregnancy after liver transplantation. Liver Transpl 7 11 suppl 1 (2001) 74
4. Armenti V., Herrine S.K., Radomski J.S., et al. Pregnancy after liver transplantation. Liver Transpl 6 (2000) 671
5. Bussutil C., and Klintmalm G.B. Transplantation of the Liver. 2nd ed. (2005), Elsevier, Philadelphia
6. Darney P.D. OC practice guidelines: minimizing side effects. Int J Fertil Womens Med suppl 1 (1997) 158
7. WHO Collaborative Study of Cardiovascular Disease and Steriod Hormone Contraception: Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 348 (1996) 505
8. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: Venous thromboembolic disease and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 346 (1995) 1575
9. Ness R.B., Grisso J.A., Klapser J., et al. Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. Am J Epidemiol 152 (2000) 233
10. Hatcher R.A., Trussel J., Stewart F., et al. Contraceptive Technology. 17th rev ed. (1998), Ardent Media, New York